Key result
Higher night-time blood pressure is linked to ~2% greater MACE risk.
Why the study?
The study aimed to evaluate the relationship between short-term outcomes, comorbidity, and ambulatory blood pressure monitoring findings in a clinical cohort of hypertensive patients.
Does night-time blood pressure predict major adverse cardiovascular events in hypertensive patients?
Cohort (n=1,521)
Does night-time blood pressure predict major adverse cardiovascular events in hypertensive patients?
Hazard Ratio: 1.018 (95% CI 1.001–1.037)
p-value: p=0.044
Night-time blood pressure measured by ABPM is an independent predictor of short-term major adverse cardiovascular events in hypertensive patients.
May support ABPM for risk stratification in hypertension; leaves open whether targeting nocturnal BP improves outcomes.
Ambulatory blood pressure monitoring (ABPM) is now considered by current guidelines to be a reliable method of measurement for the diagnosis and assessment of hypertension. The aim of this study was to relate the short-term outcomes, comorbidity and ABPM findings determined from evaluating an everyday clinical cohort of hypertensive patients. A prospective study was carried out that included hypertensive patients who had undergone 24-h ABPM from January 2016 to November 2017. The following parameters were recorded in the database: age, sex, current antihypertensive treatment and documented history of comorbidities. New episodes of myocardial infarction and stroke requiring hospitalization during follow-up obtained from electronic medical records were considered to be major adverse cardiovascular events (MACE) and were our main outcome measures. To estimate the risk of MACE, a Cox multivariate analysis was carried out. We analysed 1521 ABPM values and recorded 33 MACE during a follow-up of 518±120 days; 15 patients suffered a myocardial infarction and 18 patients had a stroke. The mean age of the patients was 59.9±14.2 years, and 49.4% were men. Night-time systolic blood pressure (BP), mean BP and pulse pressure were higher in patients who suffered a MACE. Age [hazard ratio (HR): 1.031, 95% confidence interval (CI): 1.002-1.060; P=0.036], night-time BP (HR: 1.018, 95% CI: 1.001-1.037; P=0.044) and diabetes mellitus (HR: 2.393, 95% CI: 1.053-5.436; P=0.037) were associated independently with MACE. We conclude that night-time BP is an important parameter to evaluate in aged patients with diabetes as a predictor of MACE.
No takes yet. Share an insight, caveat, or question.
Fabbian et al. (2019) conducted a cohort in Hypertension (n=1,521). Night-time blood pressure was evaluated on Major adverse cardiovascular events (MACE), defined as new episodes of myocardial infarction and stroke requiring hospitalization (HR 1.018, 95% CI 1.001-1.037, p=0.044). Higher night-time blood pressure was independently associated with an increased risk of major adverse cardiovascular events (HR 1.018; 95% CI 1.001-1.037; P=0.044).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: